Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The chromatin accessibility signature of human immune aging stems from CD8+ T cells.

Ucar D, Márquez EJ, Chung CH, Marches R, Rossi RJ, Uyar A, Wu TC, George J, Stitzel ML, Palucka AK, Kuchel GA, Banchereau J.

J Exp Med. 2017 Oct 2;214(10):3123-3144. doi: 10.1084/jem.20170416. Epub 2017 Sep 13.

2.

Reconstructing Early Industrial Contributions to Legacy Trace Metal Contamination in Southwestern Pennsylvania.

Rossi RJ, Bain DJ, Hillman AL, Pompeani DP, Finkenbinder MS, Abbott MB.

Environ Sci Technol. 2017 Apr 18;51(8):4173-4181. doi: 10.1021/acs.est.6b03372. Epub 2017 Apr 6.

PMID:
28363023
3.

Influence of Iron-Doped Apatite Nanoparticles on Viral Infection Examined in Bacterial Versus Algal Systems.

Andriolo JM, Rossi RJ, McConnell CA, Connors BI, Trout KL, Hailer MK, Pedulla ML, Skinner JL.

IEEE Trans Nanobioscience. 2016 Dec;15(8):908-916. doi: 10.1109/TNB.2016.2619349. Epub 2016 Oct 19.

PMID:
27775532
4.

Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation.

Zhang AH, Rossi RJ, Yoon J, Wang H, Scott DW.

Cell Immunol. 2016 Mar;301:74-81. doi: 10.1016/j.cellimm.2015.11.004. Epub 2015 Dec 11.

PMID:
26687613
5.

Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.

Maldonado RA, LaMothe RA, Ferrari JD, Zhang AH, Rossi RJ, Kolte PN, Griset AP, O'Neil C, Altreuter DH, Browning E, Johnston L, Farokhzad OC, Langer R, Scott DW, von Andrian UH, Kishimoto TK.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E156-65. doi: 10.1073/pnas.1408686111. Epub 2014 Dec 29.

6.

Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses.

Kim YC, Zhang AH, Su Y, Rieder SA, Rossi RJ, Ettinger RA, Pratt KP, Shevach EM, Scott DW.

Blood. 2015 Feb 12;125(7):1107-15. doi: 10.1182/blood-2014-04-566786. Epub 2014 Dec 10.

7.

Tolerance induction via B-cell delivered gene therapy.

Rossi RJ, Jackson BM, Zhang AH, Scott DW.

Methods Mol Biol. 2012;900:471-87. doi: 10.1007/978-1-60761-720-4_23.

PMID:
22933084
8.

Evaluating the effectiveness of a commercial portable air purifier in homes with wood burning stoves: a preliminary study.

Hart JF, Ward TJ, Spear TM, Rossi RJ, Holland NN, Loushin BG.

J Environ Public Health. 2011;2011:324809. doi: 10.1155/2011/324809. Epub 2011 Jan 27.

9.

The oxazolidinone derivative locostatin induces cytokine appeasement.

Ménoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, Fenteany G, Lee SJ, Rossi RJ, Mukherji B, Allen DL, Chakraborty NG, Vella AT.

J Immunol. 2009 Dec 1;183(11):7489-96. doi: 10.4049/jimmunol.0901414. Epub 2009 Nov 16.

10.

Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF.

McAleer JP, Rossi RJ, Vella AT.

J Immunol. 2009 May 1;182(9):5322-30. doi: 10.4049/jimmunol.0803616.

11.
12.

Recruitment and in situ renewal regulate rapid accumulation of CD11c+ cells in the lung following intranasal superantigen challenge.

Muralimohan G, Rossi RJ, Vella AT.

Int Arch Allergy Immunol. 2008;147(1):59-73. doi: 10.1159/000128660. Epub 2008 May 2.

13.

The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells.

McAleer JP, Zammit DJ, Lefrançois L, Rossi RJ, Vella AT.

J Immunol. 2007 Nov 15;179(10):6524-35.

14.

CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.

Lee SJ, Rossi RJ, Lee SK, Croft M, Kwon BS, Mittler RS, Vella AT.

J Immunol. 2007 Aug 15;179(4):2203-14.

15.

TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells.

Ménoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, Vella AT.

J Immunol. 2006 Nov 1;177(9):6091-7.

16.

IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.

Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL, Vella AT.

J Immunol. 2006 Jul 1;177(1):234-45.

17.

Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells.

Myers L, Lee SW, Rossi RJ, Lefrancois L, Kwon BS, Mittler RS, Croft M, Vella AT.

Int Immunol. 2006 Feb;18(2):325-33. Epub 2005 Dec 22.

PMID:
16373363
18.

Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation.

Rossi RJ, Muralimohan G, Maxwell JR, Vella AT.

Int Immunol. 2004 Dec;16(12):1751-60. Epub 2004 Oct 25.

PMID:
15504761
20.

Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Myers L, Takahashi C, Mittler RS, Rossi RJ, Vella AT.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5348-53. Epub 2003 Apr 14.

21.

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia.

Seiffert D, Stern AM, Ebling W, Rossi RJ, Barrett YC, Wynn R, Hollis GF, He B, Kieras CJ, Pedicord DL, Cromley DA, Hua TA, Stein RB, Daly RN, Sferruzza A, Pieniaszek HJ, Billheimer JT.

Blood. 2003 Jan 1;101(1):58-63. Epub 2002 Jun 28.

PMID:
12393571
22.

The effects of strapped spectacles on the fit factors of three manufactured brands of full facepiece negative pressure respirators.

Spear TM, Hardgrove R, Norman JB, Wulf DT, Rossi RJ.

Ann Occup Hyg. 1999 Apr;43(3):193-9.

PMID:
10366899
23.

Solid-phase assay for determination of binding parameters of ligand-protein complexes with high dissociation rates.

Santa-Coloma TA, Rossi RJ, Charreau EH.

Anal Biochem. 1991 Feb 1;192(2):367-71.

PMID:
1903611
24.

[Cutaneous tumor caused by arteriovenous fistula].

DE ALL J, ROSSI RJ, GENE A, KAMINSKY A.

Rev Asoc Med Argent. 1959 Oct;73:383-5. Spanish. No abstract available.

PMID:
13814622

Supplemental Content

Loading ...
Support Center